Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Immunogenetics|March 4, 2011
YBX1 expression and function in early hematopoiesis and leukemic cellsJasjeet Bhullar, Vincent E SollarsFree Radical Biology & Medicine|November 5, 2016
Microparticle formation by platelets exposed to high gas pressures - An oxidative stress responseJasjeet Bhullar, Veena M Bhopale, Ming Yang, et al.Plos One|August 23, 2013
The FLT3 inhibitor quizartinib inhibits ABCG2 at pharmacologically relevant concentrations, with implications for both chemosensitization and adverse drug interactionsJasjeet Bhullar, Karthika Natarajan, Suneet Shukla, et al.American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 19, 2015
Ascorbic acid supplementation diminishes microparticle elevations and neutrophil activation following SCUBA divingMing Yang, Otto F Barak, Zeljko Dujic, et al.Biochemical Pharmacology|December 25, 2012
The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanismsKarthika Natarajan, Jasjeet Bhullar, Suneet Shukla, et al.Molecular Cancer Therapeutics|July 11, 2012
The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2Rupashree Sen, Karthika Natarajan, Jasjeet Bhullar, et al.Pageof 1